A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis
Clinical trial NCT06875934 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06875934
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2025-11-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.